Journal
FEMS YEAST RESEARCH
Volume 10, Issue 2, Pages 221-224Publisher
OXFORD UNIV PRESS
DOI: 10.1111/j.1567-1364.2009.00595.x
Keywords
Candida albicans; aspartic peptidase inhibitor; amprenavir; fungal biology
Funding
- CNPq
- FAPERJ
- FUJB
Ask authors/readers for more resources
Secreted aspartyl peptidases (Saps) are virulence attributes produced by Candida albicans that participate in multiple aspects of the fungal biology and pathogenesis. In the present paper, we have shown that amprenavir, a peptidase inhibitor used in HIV chemotherapy, inhibited Sap2 and growth of C. albicans and also promoted ultrastructural alterations. Esterase activity, sterol content, biofilm formation and the expression of surface mannose- and sialic acid-rich glycoconjugates were also reduced by amprenavir.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available